Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
RationaleMuch evidence indicates that individuals use tobacco primarily to experience the psychopharmacological properties of nicotine. Varenicline, a partial α4β2 nicotinic acetylcholine receptor (nAChR) agonist, is effective in reducing nicotine craving and relapse in smokers, suggesting that α4β2 nAChRs may play a key role in nicotine dependence. In rats, the effect of varenicline on nicotine intake has only been studied with limited access to the drug, a model of the positive reinforcing effect of nicotine. Varenicline has not been tested on the increase in motivation to take nicotine in nicotine-dependent rats.ObjectivesThe present study evaluated the effects of varenicline on nicotine intake in rats with extended access to nicotine self-administration (23 h/day), a condition leading to the development of nicotine dependence. We hypothesized that varenicline’s effects on nicotine self-administration would be greater in rats with extended than limited access to the drug and after forced abstinence rather than during baseline self-administration.ResultsVarenicline dose-dependently decreased nicotine self-administration in rats with limited (1 h/day) and extended (23 h/day) access. Despite an increased sensitivity to the motivational effects of abstinence on nicotine intake compared with limited-access rats, varenicline was equally effective in decreasing nicotine intake in dependent rats with extended access to nicotine.ConclusionThese results suggest that α4β2 nAChRs are critical in mediating the positive reinforcing effects of nicotine but may not be a key element underlying the negative reinforcement process responsible for the increased nicotine intake after abstinence in dependent subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jorenby, D. E. (2006) · JAMA · doi:10.1001/jama.296.1.56 · Cited by 1,635 · cited 2×
“Varenicline, a partial α4β2 nicotinic acetylcholine receptor (nAChR) agonist, decreases relapse rates in humans (Gonzales et al. 2006; Jorenby et al. 2006; Tonstad et al. 2006), decreases nicotine self-administration (Rollema et al. 2007a), partially substitutes for nicotine under a progressive…”
Gonzales, D. (2006) · JAMA · doi:10.1001/jama.296.1.47 · Cited by 1,361 · cited 2×
“Varenicline, a partial α4β2 nicotinic acetylcholine receptor (nAChR) agonist, decreases relapse rates in humans (Gonzales et al. 2006; Jorenby et al. 2006; Tonstad et al. 2006), decreases nicotine self-administration (Rollema et al. 2007a), partially substitutes for nicotine under a progressive…”
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320 · cited 1×
“Elimination of the α4 or β2 nAChR subunits blocks nicotine-induced dopamine release in the nucleus accumbens and decreases nicotine self-administration (Picciotto et al. 1998; Marubio et al. 2003; Maskos et al. 2005).”
Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D. (1996) · Nature · doi:10.1038/382255a0 · Cited by 1,073 · cited 4×
“A similar decrease in nicotine self-administration has been observed after dopamine depletion of the nucleus accumbens using 6-hydroxydop- amine lesions; however, dopamine depletion did not affect abstinence-induced increases in nicotine intake observed after 3 days of forced abstinence (Corrigall et al. 1992), sugges…”
InfluentialThe mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
Corrigall, W. A., Franklin, K. B. J., Coen, K. M., & Clarke, P. B. S. (1992) · Psychopharmacology · doi:10.1007/bf02245149 · Cited by 829
Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90401-4 · Cited by 740 · cited 3×
“Although the role of α3β2, α3β4, and α7 nAChRs in nicotine reward and nicotine withdrawal is unclear (Grottick et al. 2000; Walters et al. 2006; Fowler et al. 2008), our results confirm previous reports demonstrating a key role for α4β2 nAChRs in mediating the initial positive reinforcing effects of nicotine in nondep…”
Tonstad, S. (2006) · JAMA · doi:10.1001/jama.296.1.64 · Cited by 660 · cited 2×
“…a partial α4β2 nicotinic acetylcholine receptor (nAChR) agonist, decreases relapse rates in humans (Gonzales et al. 2006; Jorenby et al. 2006; Tonstad et al. 2006), decreases nicotine self-administration (Rollema et al. 2007a), partially substitutes for nicotine under a progressive ratio…”
Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors
Maskos, U., Molles, B. E., Pons, S., Besson, M., Guiard, B. P., Guilloux, J.-P., Evrard, A., Cazala, P., Cormier, A., Mameli-Engvall, M., et al. (2005) · Nature · doi:10.1038/nature03694 · Cited by 566 · cited 1×
“Elimination of the α4 or β2 nAChR subunits blocks nicotine-induced dopamine release in the nucleus accumbens and decreases nicotine self-administration (Picciotto et al. 1998; Marubio et al. 2003; Maskos et al. 2005).”
Varenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors
Mihalak, K. B., Carroll, F. I., & Luetje, C. W. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025130 · Cited by 558
Cited by
Existing and future drugs for the treatment of the dark side of addiction
Koob, G. F., & Mason, B. J. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103143 · Cited by 121
Self-citationBordia, T., Hrachova, M., Chin, M., McIntosh, J. M., & Quik, M. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.194852 · Cited by 70
Cooperman, N. A., Hanley, A. W., Kline, A., & Garland, E. L. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108468 · Cited by 61
Metadata
- Authors
- George, O., Lloyd, A., Carroll, F. I., Damaj, M. I., & Koob, G. F.
- Venue
- Psychopharmacology
- Published
- 2010-10-06
- Volume
- 213
- Issue
- 4
- Pages
- 715-722
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2024620435
- Cited by
- 53
- References
- 25
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration. https://app.cochat.ai/papers/10.1007/s00213-010-2024-3
- The paper
- George, O., Lloyd, A., Carroll, F. I., Damaj, M. I., & Koob, G. F. (2011). Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration. Psychopharmacology. https://doi.org/10.1007/s00213-010-2024-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.